Taken together, these findings demonstrate that in a TH1-polarizing tumor microenvironment, CD8+CD161+ T-cells exhibit enhanced cytotoxicity and reduced exhaustion, potentially promoting survival in melanoma patients. The gene discussed is CD8A; the disease is melanoma.